Genentech and Renovis collaborate on protein therapeutics
Renovis Inc. and Genentech will combine their respective expertise in neurology and oncology, seeking to produce large-molecule therapeutics against CNS diseases, pathological angiogenesis, and cancer.
- Large Molecule
- Includes Contract
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com